Infectious Disease Advisor

Unlocking Access: Addressing Barriers to Clinical Trial Enrollment

Cecilia Bahit, MD, and Carolyn Lam, MBBS, PhD, FACC, discuss the barriers patients face when seeking access to clinical trial ...

Decentralized future: Expanding clinical trials by allowing people to participate from home

As the world becomes more digital, clinical research is evolving. One major change is the rise of decentralized clinical ...
GlobalData on MSN

‘The time of the Einsteins is over’: Pharma urged to rethink trials for 2050

Experts at SCOPE Europe 2025 confronted the challenges posed by rapid trial proliferation, digital transformation and ...
Morningstar

NanoViricides Dual Track Clinical Strategy Explained by a Research Report - Broad-spectrum Antiviral NV-387 At Phase II Clinical Trial Stage for MPox and also for Acute ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), reports that an analyst research report was published on the Company that explains ...